磁共振成像改善慢性肝病患者的纤维化和脂肪变性分层
本研究回顾性纳入280例慢性肝病患者,比较MRI与瞬时弹性成像对肝纤维化和脂肪变性的诊断准确性。结果显示,LSMRE对显著纤维化(F2-F4)的AUROC显著高于LSTE(0.846 vs. 0.781,P=0.046);PDFF对轻度至中度脂肪变性(S1-3和S2-3)的AUROC显著高于CAP。结论认为MRI在检测显著纤维化和轻中度脂肪变性方面诊断准确性更高。
要点
- MRI弹性成像对显著纤维化(F2-F4)的诊断准确性优于瞬时弹性成像。
- PDFF对轻度至中度脂肪变性的诊断准确性优于CAP。
- 对于重度纤维化(F3-F4、F4)和重度脂肪变性(S3),两种方法准确性相似。
诊断标准与关键数值
- LSMRE检测F2-F4的AUROC为0.846,显著高于LSTE的0.781(P=0.046)。
- LSMRE与LSTE预测F1-4、F3-4、F4的AUROC无显著差异(均P>0.05)。
- PDFF预测S1-3的AUROC为0.922,显著高于CAP的0.806(P<0.001)。
- PDFF预测S2-3的AUROC为0.924,显著高于CAP的0.795(P=0.005)。
- PDFF与CAP预测S3的AUROC无显著差异(P=0.086)。
临床应用与阅片要点
- 在慢性肝病患者的无创评估中,可优先考虑MRI弹性成像和PDFF以更准确分层显著纤维化和轻中度脂肪变性。
- 对于重度纤维化或重度脂肪变性,瞬时弹性成像仍可作为替代选择。
局限性
- 回顾性研究设计可能引入选择偏倚。
- 样本来自两家学术医院,外推性需进一步验证。
- 未报告操作者间变异性和具体设备型号。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: We aimed to compare the diagnostic accuracy of magnetic resonance imaging (MRI) and transient elastography (TE) in assessing liver fibrosis and steatosis in patients with chronic liver disease (CLD).
METHODS: Patients who underwent liver biopsy or liver surgery at two academic hospitals between 2017 and 2021 were retrospectively recruited. The stages of liver fibrosis and steatosis were evaluated using histologic examination. Liver stiffness (LS) was assessed using MR elastography (LSMRE) and TE (LSTE). Liver steatosis was assessed using proton density fat fraction (PDFF) and controlled attenuation parameter (CAP).
RESULTS: The mean age of the study population (n = 280) was 53.6 years and male sex predominated (n = 199, 71.1%). Nonalcoholic fatty liver disease was the most prevalent (n = 127, 45.5%), followed by hepatitis B virus (n = 112, 40.0%). Hepatocellular carcinoma was identified in 130 patients (46.4%). The proportions of F0, F1, F2, F3, and F4 fibrosis were 13.2%, 31.1%, 9.6%, 16.4%, and 29.7%, respectively. LSMRE had a significantly greater AUROC value than LSTE for detecting F2-F4 (0.846 vs. 0.781, P = 0.046), whereas LSMRE and LSTE similarly predicted F1-4, F3-4, and F4 (all P > 0.05). The proportions of S0, S1, S2, and S3 steatosis were 34.7%, 49.6%, 12.5%, and 3.2%, respectively. PDFF had significantly greater AUROC values than CAP in predicting S1-3 (0.922 vs. 0.806, P < 0.001) and S2-3 (0.924 vs. 0.795, P = 0.005); however, PDFF and CAP similarly predicted S3 (P = 0.086).
CONCLUSION: MRI exhibited significantly higher diagnostic accuracy than TE for detecting significant fibrosis and mild or moderate steatosis in patients with CLD.
引用
- Lee, Kim, Choi, et al. Magnetic resonance imaging improves stratification of fibrosis and steatosis in patients with chronic liver disease. Abdom Radiol (NY). 2022. PMID: 35962809. doi:10.1007/s00261-022-03618-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。